Trial Profile
A study to compare the efficacy of an extended-cycle oral contraceptive, Seasonique [ethinylestradiol/levonorgestrel + ethinylestradiol] which utilizes ethinyl estradiol during the usual hormone-free interval compared to conventional oral contraceptive therapy [ethinylestradiol/levonorgestrel] for cyclic pelvic pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol (Primary) ; Ethinylestradiol/levonorgestrel (Primary)
- Indications Dysmenorrhoea
- Focus Registrational; Therapeutic Use
- 21 Jul 2009 Actual end date (1 Jul 2007) added as reported by ClinicalTrials.gov
- 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 08 Nov 2008 Results were reported at the 64th Annual Meeting of the American Society for Reproductive Medicine.